Changming Industrial Management Group Holding (CMIM)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Changming Industrial Management Group Holding (CMIM) trades at $0.00 with AI Score 54/100 (Grade B). Changming Industrial Management Group Holding provides hospital management consultancy services to VIP maternity and gynecological centers in China, alongside managing a private hospital in Macau. Market cap: $40,836, Sector: Basic materials.
Price live · AI analysis from Jun 14, 2026Analyst Coverage for CMIM: CMIM does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates CMIM against Basic Materials peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
CMIM: 3/6 perspectives are bullish. Dominant signal: Seth Klarman bullish.
How is this calculated? →Changming Industrial Management Group Holding (CMIM) Materials & Commodity Exposure
Changming Industrial Management Group Holding operates in the specialized VIP maternity and gynecological healthcare sector, offering hospital management consultancy in China and direct hospital management in Macau. The Hong Kong-based entity, founded in 2001, caters to a niche market demanding high-end obstetric and gynecological services.
What Is the Investment Thesis for CMIM?
Changming Industrial Management Group Holding operates within the niche, high-demand segment of VIP maternity and gynecological healthcare in China and Macau, a market characterized by affluent consumers seeking premium services. The company's business model, centered on hospital management consultancy and direct hospital operations, positions it to capitalize on the growing demand for specialized healthcare. With a reported Profit Margin of 10.5% and a Gross Margin of 15.4%, the company demonstrates operational efficiency within its service delivery. The current market capitalization of 41K and a P/E ratio of 0.0 reflect its status as an OTC-listed entity with potentially limited public trading activity and valuation data. The negative Beta of -1.37 suggests a historical inverse relationship with broader market movements, which could be a point of interest for investors seeking diversification, though this metric should be considered within the context of its OTC trading environment. Key value drivers include the potential expansion of its consultancy network in China, the sustained demand for high-end birthing and gynecological services, and the operational leverage from its Macau hospital. Risks include regulatory changes in the Chinese healthcare sector and the inherent challenges of operating on the OTC market.
Based on FMP financials and quantitative analysis
CMIM Key Highlights
- The company maintains a Profit Margin of 10.5%, indicating its ability to convert revenue into net income.
- Changming Industrial Management Group Holding reports a Gross Margin of 15.4%, reflecting the profitability of its core services before operating expenses.
- With a Market Cap of 41K and a P/E ratio of 0.0, the company's public valuation metrics are currently minimal, typical for certain OTC-listed entities.
- The company's Beta is reported at -1.37, suggesting a historical inverse correlation with the broader market, though this is subject to the liquidity and trading characteristics of OTC markets.
- Changming Industrial Management Group Holding does not currently offer a dividend yield, indicating a focus on reinvestment or reflecting its current financial structure.
Who Are CMIM's Competitors?
CMIM is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ABAT American Battery Technology Company | $2.87 | +2.14% | $301.45M | 64 |
| GTMLF Green Technology Metals Limited | $0.01 | +0.00% | $8.28M | 64 |
| UAMY United States Antimony Corporation | $7.29 | -1.88% | $1.08B | 64 |
| ARRRF Ardea Resources Limited | $0.26 | -3.93% | $56.99M | 64 |
| BLSTF Blackstone Minerals Limited | $0.04 | +0.00% | $66.80M | 54 |
| STTSY The Straits Trading Company Limited | $20.37 | -0.00% | $9.20B | 54 |
| MCHHF Macmahon Holdings Limited | $0.58 | -7.94% | $1.25B | 54 |
| CBBHF Cobalt Blue Holdings Limited | $0.04 | -17.43% | $26.44M | 54 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are CMIM's Key Strengths?
- Specialized expertise in VIP maternity and gynecological healthcare services.
- Dual operational model with consultancy in China and direct hospital management in Macau.
- Established presence in the high-growth Chinese premium healthcare market.
- Demonstrated profitability with a 10.5% profit margin and 15.4% gross margin.
What Are CMIM's Weaknesses?
- Small operational scale with only 14 employees, potentially limiting expansion capacity.
- OTC market listing ('OTC Other') implies lower liquidity and transparency compared to major exchanges.
- Limited public financial disclosure status, which can deter institutional investors.
- Classification under 'Basic Materials' sector, which does not align with its healthcare operations, potentially causing investor confusion.
What Could Drive CMIM Stock Higher?
- Sustained demand for VIP maternity and gynecological services in China and Macau continues to drive the company's core business operations and consultancy engagements.
- Potential for securing new hospital management consultancy contracts with additional VIP Birthing Centers across China, expanding the company's revenue base and market reach.
- Introduction of new, high-demand specialized medical services at the private hospital managed in Macau, potentially attracting a broader patient demographic and increasing service revenue.
- Any positive developments regarding regulatory clarity or support for private healthcare providers in China could create a more favorable operating environment for CMIM's consultancy clients.
What Are the Key Risks for CMIM?
- Financial-distress signal — its Altman Z-Score of -31.91 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Regulatory changes and policy shifts within the Chinese and Macau healthcare sectors could impact operations, service pricing, or market access for CMIM and its clients.
- Intense competition from established domestic and international private healthcare groups in the VIP maternity and gynecological segment could pressure market share and profitability.
- Reliance on a specialized niche market means the company's performance is highly sensitive to economic downturns that affect discretionary spending on premium healthcare services.
- The 'OTC Other' listing and 'Unknown' disclosure status present significant risks related to liquidity, price discovery, and investor confidence due to limited transparency.
- Operational challenges or negative publicity associated with the private hospital in Macau or any of its consultancy clients could damage the company's reputation and business prospects.
What Are the Growth Opportunities for CMIM?
- Expansion of VIP Maternity and Gynecological Consultancy Services: The increasing affluence in China fuels a demand for premium healthcare services. CMIM can capitalize on this by expanding its network of consultancy contracts with new VIP Birthing Centers across Tier 1 and Tier 2 cities in China. The market for high-end private healthcare is projected to continue growing, driven by consumer preference for personalized care and advanced facilities. By leveraging its established expertise, CMIM could secure additional management agreements, thereby increasing its revenue streams through service fees.
- Deepening Service Offerings within Existing Operations: Beyond core obstetric and gynecological services, CMIM has an opportunity to introduce complementary high-value services. This could include advanced fertility treatments, specialized pediatric care, wellness programs for new mothers, or expanded aesthetic services. Such diversification within its managed hospital in Macau and its consultancy clients in China could enhance patient lifetime value and attract a broader clientele, increasing average revenue per patient. This strategy could be implemented over the next 3-5 years, depending on market demand and regulatory approvals.
- Geographic Expansion within Macau and Neighboring Regions: While CMIM currently manages one private hospital in Macau, there is potential for further expansion within the Special Administrative Region or into adjacent areas with similar demographic and economic profiles. This could involve acquiring or developing new facilities, or forming strategic partnerships with local healthcare providers. Such expansion would allow CMIM to leverage its operational expertise and brand recognition in the region, tapping into a broader patient base and increasing its market share in the premium healthcare segment over a 5-year horizon.
- Leveraging Technology for Enhanced Patient Experience and Operational Efficiency: Investing in and integrating advanced healthcare technologies presents a significant growth avenue. This includes telemedicine platforms for remote consultations, AI-powered diagnostics, digital patient records, and smart hospital management systems. Implementing such technologies could improve service delivery, reduce operational costs, and enhance the patient experience, making CMIM's managed facilities more attractive. This could also be offered as a value-added service to its consultancy clients, strengthening its competitive edge in the market over the next 2-4 years.
- Strategic Partnerships and Acquisitions in the Healthcare Management Sector: CMIM could pursue strategic partnerships or targeted acquisitions of smaller, specialized healthcare providers or management companies. This inorganic growth strategy would allow the company to quickly expand its geographic reach, diversify its service portfolio, or gain access to new technologies and talent. Focusing on companies that align with its VIP healthcare niche would ensure synergy and market consolidation, potentially leading to increased market share and operational scale over the medium term (3-7 years).
What Opportunities Does CMIM Have?
- Growing demand for high-end, specialized healthcare services among affluent populations in China and Macau.
- Potential for geographic expansion of consultancy services to more VIP centers in China.
- Diversification into complementary high-value medical services within its existing operations.
- Strategic partnerships or acquisitions to expand market reach and service offerings.
What Threats Does CMIM Face?
- Evolving and potentially restrictive healthcare regulations in China and Macau.
- Intense competition from other private healthcare providers and public hospital VIP departments.
- Economic downturns impacting discretionary spending on premium healthcare services.
- Risks associated with the OTC market, including price volatility and difficulty in raising capital.
What Are CMIM's Competitive Advantages?
- Specialized focus on VIP maternity and gynecological services, catering to a niche market with high demand for quality.
- Established presence and operational experience in both mainland China (consultancy) and Macau (direct hospital management).
- Expertise in managing high-end healthcare facilities, ensuring premium service delivery and patient experience.
- Reputation and brand recognition within the specific segment of the Chinese and Macau healthcare markets.
What Does CMIM Do?
Changming Industrial Management Group Holding, founded in 2001 and headquartered in Wan Chai, Hong Kong, has evolved into a specialized provider within the healthcare management sector. Initially known as China Health Care Corporation, the company rebranded in February 2019 to its current name, reflecting its strategic focus. The core of its business involves delivering hospital management consultancy services specifically to VIP maternity and gynecological centers, often referred to as VIP Birthing Centers, across mainland China. This consultancy encompasses operational optimization, service quality enhancement, and strategic development for these high-end facilities. In addition to its consultancy arm, Changming Industrial Management Group Holding directly manages a private hospital located in Macau, further solidifying its operational footprint in the Greater China region. The company's service portfolio is comprehensive, covering both obstetric and gynecological specialties. Obstetric services include outpatient offerings such as pre-delivery check-ups, consultations, and prenatal genetic consultations, alongside inpatient and minor surgery services like vaginal births, caesarean sections, and prenatal education programs. For gynecology, the company provides various outpatient services, including general gynecologic check-ups and pre-marriage body check-ups. Its inpatient and minor surgery services in gynecology encompass minor operations and procedures for planned childbirth. With a lean operational structure, employing 14 individuals, Changming Industrial Management Group Holding positions itself as a focused player in the premium segment of the Chinese and Macau healthcare markets, addressing the demand for specialized, high-quality medical services.
What Products and Services Does CMIM Offer?
- Provides hospital management consultancy services to VIP maternity and gynecological centers in China.
- Manages a private hospital located in Macau, overseeing its operations and service delivery.
- Offers comprehensive obstetric services, including outpatient pre-delivery check-ups and consultations.
- Delivers inpatient obstetric services such as vaginal births, caesarean sections, and prenatal education.
- Provides prenatal genetic consultation services to expectant mothers.
- Offers various gynecologic outpatient services, including general check-ups and pre-marriage body check-ups.
- Performs inpatient and minor surgery services for gynecology, including minor operations and planned childbirth procedures.
- Focuses on the premium segment of the healthcare market, catering to VIP clients seeking specialized care.
How Does CMIM Make Money?
- Generates revenue through consultancy fees charged to VIP maternity and gynecological centers in China for management services.
- Earns income from direct patient service fees at the private hospital it manages in Macau for obstetric and gynecological treatments.
- Provides a range of specialized medical services, from outpatient consultations to inpatient surgeries, for which patients pay directly or through insurance.
- Leverages its expertise in high-end healthcare operations to optimize efficiency and service quality for its clients and managed facilities.
What Industry Does CMIM Operate In?
Changming Industrial Management Group Holding operates within the specialized segment of healthcare management, specifically targeting VIP maternity and gynecological services in China and Macau. While officially classified under the 'Basic Materials' sector and 'Industrial Materials' industry, its operational focus is squarely within healthcare. The broader Chinese healthcare market is experiencing significant growth, driven by an aging population, rising disposable incomes, and increasing demand for higher-quality, specialized medical services. The VIP segment, in particular, benefits from a growing middle and affluent class willing to pay premiums for personalized care, advanced facilities, and enhanced patient experiences. The competitive landscape includes both domestic and international private healthcare providers, as well as public hospitals with VIP departments. CMIM distinguishes itself through its dual model of management consultancy for third-party centers and direct operation of a private hospital, carving out a niche in a fragmented yet expanding market. The demand for specialized women's health services, particularly in urban centers, continues to be a significant trend.
Who Are CMIM's Key Customers?
- VIP maternity and gynecological centers in China seeking expert management and operational consultancy.
- Individual patients in Macau utilizing the private hospital for obstetric services, including pre-delivery care, births, and prenatal education.
- Individual patients in Macau seeking gynecological services, such as check-ups, consultations, and minor operations.
- Affluent individuals and families in China and Macau who prioritize premium, specialized healthcare services.
Company Profile
Changming Industrial Management Group Holding operates in the Industrial Materials industry within the Basic Materials sector. It is headquartered in Wan Chai, HK. The company is led by CEO Koon Fai Lam. CMIM has traded publicly since 2008.
How Changming Industrial Management Group Holding Is Valued
Changming Industrial Management Group Holding carries a market capitalization of 41K, placing it in the micro-cap category. Relative to its peer group, CMIM's quantitative score of 54/100 is roughly in line with the peer average of 62/100.
ROE 62%Key Financial Metrics
Return on equity for Changming Industrial Management Group Holding stands at 61.9%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 37.4%, showing how much profit it generates from its asset base. CMIM trades at a trailing price-to-earnings ratio of 0.00, below the Basic Materials sector average of ~22x. A current ratio of 3.71 indicates the company holds enough short-term assets to cover its near-term obligations.
F-Score 2/9Financial Health
Changming Industrial Management Group Holding's Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -31.91 places it in the distress zone, a signal of elevated financial risk.
CMIM Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Specialized expertise in VIP maternity and gynecological healthcare services.
- Dual operational model with consultancy in China and direct hospital management in Macau.
- Established presence in the high-growth Chinese premium healthcare market.
- Demonstrated profitability with a 10.5% profit margin and 15.4% gross margin.
Bear Case
- Small operational scale with only 14 employees, potentially limiting expansion capacity.
- OTC market listing ('OTC Other') implies lower liquidity and transparency compared to major exchanges.
- Limited public financial disclosure status, which can deter institutional investors.
- Classification under 'Basic Materials' sector, which does not align with its healthcare operations, potentially causing investor confusion.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
CMIM Latest News
No recent news available for CMIM.
CMIM Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CMIM.
Price Targets
Wall Street price target analysis for CMIM.
CMIM MoonshotScore
What does this score mean?
The MoonshotScore rates CMIM's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Koon Fai Lam
Managing Director
Koon Fai Lam serves as the Managing Director of Changming Industrial Management Group Holding, overseeing the strategic direction and daily operations of the company. While specific details regarding his prior career history and educational background are not publicly available, his leadership is central to the company's focus on specialized VIP maternity and gynecological services. In his capacity, Mr. Lam is responsible for guiding the company's consultancy services to VIP Birthing Centers in China and managing the private hospital in Macau, ensuring the delivery of high-quality healthcare services and operational efficiency for the company's 14 employees.
Track Record: Under Koon Fai Lam's leadership, Changming Industrial Management Group Holding has continued its operations in the niche VIP healthcare market since its name change in 2019. His tenure has involved maintaining the company's focus on hospital management consultancy and direct hospital operations in Macau. While specific achievements or strategic decisions are not detailed in public records, his role is integral to the ongoing management and service delivery within the company's specialized healthcare segments.
CMIM OTC Market Information
Changming Industrial Management Group Holding trades on the 'OTC Other' tier of the OTC market. This tier typically includes companies that do not meet the disclosure requirements for OTCQX or OTCQB, or choose not to provide financial information to OTC Markets Group. Unlike companies listed on major exchanges like NYSE or NASDAQ, which have stringent listing standards regarding financial reporting, corporate governance, and minimum share prices, 'OTC Other' companies have significantly fewer regulatory obligations. This tier is often associated with a higher degree of risk due to limited public information and less oversight, making it challenging for investors to conduct thorough due diligence.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited Public Information: The 'Unknown' disclosure status means investors have restricted access to financial statements and operational updates, increasing informational asymmetry and investment risk.
- Low Liquidity and Volatility: Trading on the 'OTC Other' tier often results in extremely low trading volumes, wide bid-ask spreads, and significant price volatility, making it difficult to buy or sell shares.
- Lack of Regulatory Oversight: Companies on 'OTC Other' are subject to minimal regulatory scrutiny compared to exchange-listed companies, offering less protection for investors.
- Potential for Fraud and Manipulation: The less regulated environment of 'OTC Other' markets can be more susceptible to fraudulent activities and market manipulation.
- Difficulty in Valuation: The absence of consistent financial reporting and active trading makes it challenging to accurately value the company and assess its true financial health.
- Attempt to locate any available financial statements or annual reports directly from the company or third-party sources.
- Research any news or press releases issued by the company, even if not formally filed, to understand recent developments.
- Investigate any regulatory filings in Hong Kong or Macau related to its operations, if applicable.
- Assess the company's business model and market niche for viability and competitive advantages, independent of financial data.
- Understand the management team's background and experience, seeking any available professional profiles.
- Evaluate the specific risks associated with investing in the Chinese and Macau healthcare sectors, including regulatory changes.
- Consider the implications of the 'Basic Materials' sector classification for a healthcare services company.
- The company has a clearly defined business model focused on specialized healthcare services in China and Macau.
- It has a physical headquarters in Wan Chai, Hong Kong, indicating a tangible operational base.
- The company has a founding year (2001) and a documented name change (2019), suggesting a history of operations.
- It manages a private hospital in Macau, implying real-world assets and operational responsibilities.
- The company's CEO, Koon Fai Lam, is identified, providing a point of contact for leadership.
CMIM Basic Materials Stock FAQ
What services does Changming Industrial Management Group Holding provide?
Changming Industrial Management Group Holding specializes in providing hospital management consultancy services to VIP maternity and gynecological centers across China. Additionally, the company directly manages a private hospital in Macau. Its service offerings are comprehensive, encompassing both obstetric and gynecological care. For obstetrics, this includes outpatient services like pre-delivery check-ups, consultations, and prenatal genetic consultations, as well as inpatient services such as vaginal births, caesarean sections, and prenatal education. In gynecology, the company provides outpatient services like general gynecologic check-ups and pre-marriage body check-ups, alongside inpatient and minor surgery services for various gynecological procedures. The company targets a premium market segment, focusing on high-quality, specialized medical care.
What are the key financial metrics investors watch for CMIM?
For Changming Industrial Management Group Holding, investors typically monitor several key financial metrics, particularly given its specialized healthcare services and OTC listing. The Profit Margin of 10.5% and Gross Margin of 15.4% are important indicators of the company's operational efficiency and profitability in its niche market. Given its 41K Market Cap and 0.00 P/E, traditional valuation metrics are currently limited, suggesting a focus on underlying business performance. The Beta of -1.37, while potentially indicative of an inverse market relationship, should be interpreted cautiously due to the illiquid nature of OTC trading. Investors would also look for any available revenue growth figures, cash flow generation, and debt levels, though these are not explicitly provided in the current data, emphasizing the need for robust due diligence.
What are the primary challenges or risks associated with investing in CMIM?
Investing in Changming Industrial Management Group Holding carries several specific challenges and risks. A primary concern is its listing on the 'OTC Other' tier with an 'Unknown' disclosure status, leading to very limited public financial information and low trading liquidity, which can make share valuation and trading difficult. The company operates in the highly regulated healthcare sectors of China and Macau, making it susceptible to policy changes that could impact its business model or profitability. Furthermore, its reliance on the VIP segment of maternity and gynecological services means it is vulnerable to economic fluctuations that affect discretionary spending on premium healthcare. Competition from other private healthcare providers also poses a significant threat to market share and pricing power. The small employee base of 14 might also suggest limited capacity for rapid expansion or resilience to operational disruptions.
How does Changming Industrial Management Group Holding position itself in the Chinese VIP healthcare market?
Changming Industrial Management Group Holding positions itself as a specialized provider in the premium segment of the Chinese and Macau healthcare markets by focusing exclusively on VIP maternity and gynecological services. It employs a dual strategy: offering hospital management consultancy to third-party VIP Birthing Centers in China and directly managing a private hospital in Macau. This allows the company to leverage its expertise in high-end service delivery, operational efficiency, and patient experience across different operational models. By catering to affluent clients seeking specialized care, advanced facilities, and personalized attention, CMIM differentiates itself from broader healthcare providers. Its niche focus on women's health, from prenatal care to gynecological procedures, allows it to build deep expertise and a reputation within this specific, high-value market segment.
What is the significance of CMIM's OTC listing and its 'OTC Other' tier?
Changming Industrial Management Group Holding's listing on the 'OTC Other' tier of the OTC market signifies a distinct set of implications for investors compared to companies on major exchanges. The 'OTC Other' tier is the lowest of the OTC tiers, typically for companies with minimal or no public disclosure, which is consistent with CMIM's 'Unknown' disclosure status. This means there is significantly less regulatory oversight and transparency, making it challenging to access reliable financial data and operational updates. Consequently, CMIM shares are likely to have very low liquidity, wide bid-ask spreads, and higher price volatility. This environment often translates to higher investment risk due to the difficulty in valuing the company, executing trades, and the potential for limited investor protection. It suggests the company may not meet the listing requirements or choose not to comply with the reporting standards of higher tiers or national exchanges.
What are the key factors to evaluate for CMIM?
Changming Industrial Management Group Holding (CMIM) holds an AI score of 54/100 (moderate). P/E: 0.0x vs the S&P 500's ~20-25x. Not financial advice.
How frequently does CMIM data refresh on this page?
CMIM prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven CMIM's recent stock price performance?
Changming Industrial Management Group Holding (CMIM) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Specialized expertise in VIP maternity and gynecological healthcare services. See the News tab for the latest drivers. Past performance does not predict future results.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited financial data provided, necessitating inference for some sections, particularly regarding growth opportunities, catalysts, and risks.
- The company's classification under 'Basic Materials' sector is noted but the analysis focuses on its actual healthcare services business.
- Specific details on CEO's background and track record are not available in the provided source, leading to general descriptions based on role.